Evidence map›Paper›PMID 37975229›Full record

ArticleHypertension (Dallas, Tex. : 1979)2024

2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.

Bart Spronck, Dimitrios Terentes-Printzios, Alberto P Avolio, Pierre Boutouyrie, Andrea Guala, Ana Jerončić, Stéphane Laurent, Eduardo C D Barbosa, Johannes Baulmann, Chen-Huan Chen and 18 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06836622 (Correlation Between the Values of Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity), which is not on this map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06836622 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Correlation Between the Values of Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity

TypeobservationalSponsorHospital de BaseRan2026 to 2027Enrolled350ConditionsHypertension, Arterial Stiffness, Pulse Wave Analysis, Pulse Wave Velocity
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. ENAC blockade reduces blood pressure and arterial stiffness in adults with obesity and insulin resistance.American journal of physiology. Heart and circulatory physiology · 2026
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Wearable Flexible Sensors for Cardiovascular Disease Monitoring.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  13. Vascular Age: A narrative review of assessment methods, clinical applications, and future directions.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 19 countries.

Bart SpronckDepartment of Biomedical Engineering, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Netherlands (B.S.).ORCID 0000-0003-1076-1922
Dimitrios Terentes-Printzios1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Greece (D.T.-P., C.V.).ORCID 0000-0003-4039-8263
Alberto P AvolioMacquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia (B.S., A.P.A., I.T.).ORCID 0000-0002-8311-2010
Pierre BoutouyrieUniversité Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), France (P.B., S.L., R.M.B.).ORCID 0000-0002-4375-3569
Andrea GualaVall d'Hebron Institut de Recerca, Barcelona, Spain (A.G.).ORCID 0000-0002-5006-8164
Ana JerončićLaboratory of Vascular Aging and Cardiovascular Prevention, Department of Research in Biomedicine and Health, University of Split School of Medicine, Croatia (A.J.).
Stéphane LaurentUniversité Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), France (P.B., S.L., R.M.B.).ORCID 0000-0002-4697-405X
Eduardo C D BarbosaFeevale University, Santa Casa Hospital, Porto Alegre, Brazil (E.C.D.B).
Johannes BaulmannPraxis Dres. Gille/Baulmann, Rheinbach, Germany (J.B.).ORCID 0000-0002-4446-8540
Chen-Huan ChenCollege of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (C.-H.C.).ORCID 0000-0002-9262-0287
Julio A ChirinosCardiovascular Division, University of Pennsylvania Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia, PA (J.A.C.).ORCID 0000-0001-9035-5670
Stella S DaskalopoulouDepartment of Medicine, Research Institute McGill University Health Centre, McGill University, Montreal, QC, Canada (S.S.D.).ORCID 0000-0003-4774-2549
Alun D HughesDepartment of Population Science and Experimental Medicine, Institute of Cardiovascular Science, University College London, United Kingdom (A.D.H.).ORCID 0000-0001-5432-5271
Azra MahmudDepartment of Internal Medicine, Pharmacology, and Clinical Research, Shalamar Medical and Dental College, Lahore, Pakistan (A.M.).ORCID 0000-0002-1927-8139
Christopher C MayerAIT Austrian Institute of Technology, Center for Health & Bioresources, Medical Signal Analysis, Vienna (C.C.M.).ORCID 0000-0002-5612-5481
Jeong Bae ParkJB Lab and Clinic, Department of Precision Medicine and Biostatistics, Wonju College of Medicine, Yonsei University, Seoul, Republic of Korea (J.B.P.).ORCID 0000-0002-5623-7010
Gary L PierceDepartment of Health and Human Physiology, University of Iowa, IA (G.L.P.).ORCID 0000-0001-7499-080X
Aletta E SchutteSchool of Population Health, University of New South Wales, Sydney, Australia (A.E.S.).ORCID 0000-0001-9217-4937
Elaine M UrbinaCincinnati Children's Hospital Medical Center, OH (E.M.U.).ORCID 0000-0002-5640-6777
Ian B WilkinsonExperimental Medicine and Therapeutics, University of Cambridge, United Kingdom (I.B.W.).
Patrick SegersIBiTech-BioMMedA, Ghent University, Belgium (P.S.).ORCID 0000-0003-3870-3409
James E SharmanMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia (J.E.S.).ORCID 0000-0003-2792-0811
Isabella TanMacquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia (B.S., A.P.A., I.T.).ORCID 0000-0003-3123-6190
Charalambos Vlachopoulos1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Greece (D.T.-P., C.V.).ORCID 0000-0002-9904-3558
Thomas WeberCardiology Department, Klinikum Wels-Grieskirchen, Austria (T.W.).ORCID 0000-0003-0617-0417
Elisabetta BianchiniInstitute of Clinical Physiology, Italian National Research Council, Pisa (E.B.).ORCID 0000-0002-1827-8866
Rosa Maria BrunoUniversité Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), France (P.B., S.L., R.M.B.).ORCID 0000-0002-6107-3356
Association for Research into Arterial Structure and Physiology (ARTERY), the European Society of Hypertension Working Group on Large Arteries, European Cooperation in Science and Technology (COST) Action VascAgeNet, North American Artery Society, ARTERY LATAM, Pulse of Asia, and Society for Arterial Stiffness—Germany-Austria-Switzerland (DeGAG)
Inserm · FRHippocration General Hospital · GRAustrian Institute of Technology · ATCincinnati Children's Hospital Medical Center · USHospital of the University of Pennsylvania · USiMinds · BEInstituto de Salud Carlos III · ESKlinikum Wels-Grieskirchen · ATMaastricht University · NLMacquarie University · AUMcGill University Health Centre · CAMedical University of Graz · ATNational Academies of Sciences, Engineering, and Medicine · USNational Yang Ming Chiao Tung University · TWSanta Casa Hospital · BRShalamar Hospital · PKThe George Institute for Global Health · AUThe University of Sydney · AUTwitter (United States) · USUniversity of Cambridge · GB

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)R01AG058969 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Timothy M. Hughes, YONGMEI LIU · 2018 to 2026
$33.4M
Understanding the relationship between obesity and tongue fat in humans and ratsP01HL094307 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 2009 to 2020
$23.7M
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BPR01HL104106 · NHLBI · UNIVERSITY OF DELAWARE · PI EDWARDS, DAVID G, FARQUHAR, WILLIAM B · 2011 to 2021
$4.5M
Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEFR01HL155599 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ZAMANI, PAYMAN · 2021 to 2025
$3.9M
Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEFR01HL157264 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ZAMANI, PAYMAN · 2021 to 2025
$3.5M
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)R01HL153646 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI COHEN, JORDANA B. · 2020 to 2024
$3.2M
Efficacy of Potassium Nitrate in Heart Failure with Preserved Ejection FractionR01HL121510 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHIRINOS MEDINA, JULIO ALONSO · 2015 to 2019
$3.1M
Developing Oral LT3 Therapy for Heart FailureR33HL146390 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CAPPOLA, ANNE R, CAPPOLA, THOMAS P. · 2020 to 2022
$2.2M
Efficacy of Fenofibrate for COVID-19: A phase II randomized controlled trialU01TR003734 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI CHIRINOS MEDINA, JULIO ALONSO · 2021 to 2021
$1.8M
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical CentersU01HL160277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI JULIO ALONSO CHIRINOS MEDINA · 2021 to 2026
$1.7M
Sympathetic Regulation of Large Artery Stiffness in Humans with Age-Related Isolated Systolic HypertensionR01AG063790 · NIA · UNIVERSITY OF IOWA · PI PIERCE, GARY L. · 2020 to 2024
$1.7M
NCATS NIH HHS U01 TR003734NHLBI NIH HHS P01 HL094307NHLBI NIH HHS R01 HL104106NHLBI NIH HHS R01 HL121510NHLBI NIH HHS R01 HL153646NHLBI NIH HHS R01 HL155599NHLBI NIH HHS R01 HL157264NHLBI NIH HHS R03 HL146874NHLBI NIH HHS R33 HL146390NHLBI NIH HHS R56 HL136730NHLBI NIH HHS U01 HL160277NIA NIH HHS K24 AG070459NIA NIH HHS R01 AG058969NIA NIH HHS R01 AG063790NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

backgroundArterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new devices for assessing PWV, it has become evident that some of these devices yield results that display significant discrepancies compared with previous devices. This discrepancy underscores the importance of comprehensive validation procedures and the need for international recommendations.

methodsA stepwise approach utilizing the modified Delphi technique, with the involvement of key scientific societies dedicated to arterial stiffness research worldwide, was adopted to formulate, through a multidisciplinary vision, a shared approach to the validation of noninvasive arterial PWV measurement devices.

resultsA set of recommendations has been developed, which aim to provide guidance to clinicians, researchers, and device manufacturers regarding the validation of new PWV measurement devices. The intention behind these recommendations is to ensure that the validation process can be conducted in a rigorous and consistent manner and to promote standardization and harmonization among PWV devices, thereby facilitating their widespread adoption in clinical practice.

conclusionsIt is hoped that these recommendations will encourage both users and developers of PWV measurement devices to critically evaluate and validate their technologies, ultimately leading to improved consistency and comparability of results. This, in turn, will enhance the clinical utility of PWV as a valuable tool for assessing arterial stiffness and informing cardiovascular risk stratification and management in individuals with hypertension.

Indexed as

HypertensionVascular StiffnessArterial PressureArteriesHumansPulse Wave Analysisaortacardiovascular diseasesguidelinemethodspulse wave analysisvascular stiffness

Identifiers

PMID37975229
PMCPMC10734786
OpenAlexW4388774810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.